All News about Regeneron Pharmaceuticals
Analyst Ratings for Regeneron Pharmaceuticals
January 11, 2023
Via Benzinga
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2023
January 20, 2023
Via Benzinga
Regeneron-Sanofi's Dupixent Wins European Approval For Prurigo Nodularis
December 15, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|